TY - JOUR
T1 - Direct Evidence of Abortive Lytic Infection-Mediated Establishment of Epstein-Barr Virus Latency During B-Cell Infection
AU - Inagaki, Tomoki
AU - Sato, Yoshitaka
AU - Ito, Jumpei
AU - Takaki, Mitsuaki
AU - Okuno, Yusuke
AU - Yaguchi, Masahiro
AU - Masud, H. M.Abdullah Al
AU - Watanabe, Takahiro
AU - Sato, Kei
AU - Iwami, Shingo
AU - Murata, Takayuki
AU - Kimura, Hiroshi
N1 - Funding Information:
We thank Wolfgang Hammerschmidt, Henri-Jacques Delecluse, Hironori Yoshiyama, Connie Cepko, Gerhart Ryffel, Hiroyuki Miyoshi, Yasuo Ariumi, and Didier Trono for providing invaluable materials; Shuko Kumagai, Mai Suganami, and Tomoko Kunogi for technical support; and the Division for Medical Research Engineering at Nagoya University Graduate School of Medicine for technical support of cell sorting and next-generation sequencing. We also thank Enago (www.enago.jp) for the English language review. This manuscript has been released as a pre-print at bioRxiv, Inagaki et al. (2020). Funding. This work was supported in part by grants from the Japan Society for the Promotion of Science (JSPS) KAKENHI (https://www.jsps.go.jp) (Grant nos. JP16H06231 to YS, JP18H02662 to KS, JP19H04829 to YS, JP20H03493 to HK, JP19H04826 to KS, JP19H04839 to SI, and JP17H04081 to KS); the JST (https://www.jst.go.jp) PRESTO (Grant no. JPMJPR19H5) to YS; JST MIRAI (Grant no. 18077147) to IS; the Japan Agency for Medical Research and Development (AMED, https://www.amed.go.jp) (JP19fm0208016 and JP20wm0325012 to TM, JP19ck0106517 to YO, and JP19jk0210023 to YS); the Takeda Science Foundation (https://www.takeda-sci.or.jp) to YS and TM; the 24th General Assembly of the Japanese Association of Medical Sciences to YS; the Hori Sciences and Arts Foundation (https://www.hori-foundation.or.jp) to YS and HK; and the MSD Life Science Foundation (https://www.msd-life-science-foundation.or.jp) to YS. TI is supported by the Takeda Science Foundation scholarship. JI is supported by the JSPS Research fellowship (19J01713).
Publisher Copyright:
© Copyright © 2021 Inagaki, Sato, Ito, Takaki, Okuno, Yaguchi, Masud, Watanabe, Sato, Iwami, Murata and Kimura.
PY - 2021/1/21
Y1 - 2021/1/21
N2 - Viral infection induces dynamic changes in transcriptional profiles. Virus-induced and antiviral responses are intertwined during the infection. Epstein-Barr virus (EBV) is a human gammaherpesvirus that provides a model of herpesvirus latency. To measure the transcriptome changes during the establishment of EBV latency, we infected EBV-negative Akata cells with EBV-EGFP and performed transcriptome sequencing (RNA-seq) at 0, 2, 4, 7, 10, and 14 days after infection. We found transient downregulation of mitotic division-related genes, reflecting reprogramming of cell growth by EBV, and a burst of viral lytic gene expression in the early phase of infection. Experimental and mathematical investigations demonstrate that infectious virions were not produced in the pre-latent phase, suggesting the presence of an abortive lytic infection. Fate mapping using recombinant EBV provided direct evidence that the abortive lytic infection in the pre-latent phase converges to latent infection during EBV infection of B-cells, shedding light on novel roles of viral lytic gene(s) in establishing latency. Furthermore, we find that the BZLF1 protein, which is a key regulator of reactivation, was dispensable for abortive lytic infection in the pre-latent phase, suggesting the divergent regulation of viral gene expressions from a productive lytic infection.
AB - Viral infection induces dynamic changes in transcriptional profiles. Virus-induced and antiviral responses are intertwined during the infection. Epstein-Barr virus (EBV) is a human gammaherpesvirus that provides a model of herpesvirus latency. To measure the transcriptome changes during the establishment of EBV latency, we infected EBV-negative Akata cells with EBV-EGFP and performed transcriptome sequencing (RNA-seq) at 0, 2, 4, 7, 10, and 14 days after infection. We found transient downregulation of mitotic division-related genes, reflecting reprogramming of cell growth by EBV, and a burst of viral lytic gene expression in the early phase of infection. Experimental and mathematical investigations demonstrate that infectious virions were not produced in the pre-latent phase, suggesting the presence of an abortive lytic infection. Fate mapping using recombinant EBV provided direct evidence that the abortive lytic infection in the pre-latent phase converges to latent infection during EBV infection of B-cells, shedding light on novel roles of viral lytic gene(s) in establishing latency. Furthermore, we find that the BZLF1 protein, which is a key regulator of reactivation, was dispensable for abortive lytic infection in the pre-latent phase, suggesting the divergent regulation of viral gene expressions from a productive lytic infection.
UR - http://www.scopus.com/inward/record.url?scp=85101114267&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101114267&partnerID=8YFLogxK
U2 - 10.3389/fmicb.2020.575255
DO - 10.3389/fmicb.2020.575255
M3 - Article
AN - SCOPUS:85101114267
SN - 1664-302X
VL - 11
JO - Frontiers in Microbiology
JF - Frontiers in Microbiology
M1 - 575255
ER -